Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vicarious Surgical Inc. (RBOT)

NYSE - Nasdaq Real Time Price. Currency in USD
0.7093-0.0369 (-4.95%)
At close: 04:00PM EDT
0.7440 +0.03 (+4.89%)
After hours: 07:30PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close0.7462
Open0.7621
Bid0.7150 x 1000
Ask0.7248 x 900
Day's Range0.7000 - 0.7700
52 Week Range0.7000 - 3.9900
Volume397,607
Avg. Volume1,035,603
Market Cap122.215M
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-0.6000
Earnings DateJul 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RBOT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vicarious Surgical Inc.
    Analyst Report: Stryker CorporationStryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
  • Business Wire

    Vicarious Surgical Receives Continued Listing Standard Notice From NYSE

    WALTHAM, Mass., September 22, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20, 2023, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average c

  • Business Wire

    Vicarious Surgical Announces New Hospital System Partnership with Intermountain Health

    WALTHAM, Mass., September 12, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to enhance patient outcomes and improve the cost and efficiency of surgical procedures, announced it has signed a strategic development agreement with Intermountain Health, a leading U.S. healthcare system.

  • Business Wire

    Vicarious Surgical to Present at the Gilmartin Group Emerging Growth Company Showcase

    WALTHAM, Mass., September 07, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Advertisement
Advertisement